Septin 10 Activators constitute a chemical class that indirectly modulates the activity or function of Septin 10 (SEPT10), a member of the septin family of GTP-binding proteins. SEPT10 is involved in a myriad of cellular functions, notably in cytoskeletal organization, cell division, and vesicle trafficking. The activation of SEPT10 is a nuanced process, often involving the modulation of its interaction with other cellular components rather than direct stimulation of its enzymatic activity. Activators in this class typically influence the cellular environment or signaling pathways that indirectly affect SEPT10. They may act by altering the dynamics of the cytoskeleton, modulating GTP-binding processes, or influencing cellular signaling pathways. For instance, compounds that stabilize microtubules or affect actin polymerization can indirectly impact SEPT10, given its role in cytoskeletal organization. Furthermore, activators that influence signaling pathways like Rho kinase (ROCK) or Phosphoinositide 3-kinase (PI3K), which are integral to cell division and cytoskeletal reorganization, may also indirectly modulate SEPT10 function.
The biochemical impact of Septin 10 Activators extends to various fundamental cellular processes. By affecting cytoskeletal dynamics, these activators can influence cell shape, motility, and division, all processes in which septins like SEPT10 are integral players. For example, modulation of microtubule and actin dynamics can indirectly influence SEPT10's involvement in these processes. Moreover, the regulation of GTPase activity, a crucial aspect of septin function, is another potential mechanism of action for these activators. This is particularly relevant considering SEPT10's role in GTP-binding and hydrolysis. The impact of these activators on signaling pathways underscores the complex interplay between septins and cellular signaling networks. By modulating pathways that govern cell stress responses, proliferation, and survival, Septin 10 Activators can indirectly orchestrate the spatial and temporal dynamics of SEPT10, thereby influencing its participation in critical cellular activities. The study of these activators contributes to a deeper understanding of septin biology and the sophisticated regulatory mechanisms governing cellular architecture and dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
A chemotherapy agent in research used to treat a number of types of cancer; stabilizes microtubules. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of phosphatidylinositol 3-kinase, used in research to study PI3K signaling pathways. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A agent in research used to treat high blood pressure and a number of other conditions; modulates calcium signaling. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor used in chemotherapy for treating multiple myeloma and mantle cell lymphoma. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor used in research and cancer research. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
A agent in research used to treat certain types of cancer; a tyrosine kinase inhibitor. | ||||||